A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being developed in Hamilton after a McMaster University researcher discovered a new fungal compound that could improve brain health. https://t.co/xZUwgbvcQj

McMaster University remains one of Canada’s top research universities, based on the annual rankings published today by @R_Infosource. #CIL2024 @McMasterU earned the top spot for research income growth and for graduate student research intensity.

New from @Macleans: How @ItsJonStokes is working at the intersect of academia and industry to get new antibiotics to the finish line faster. https://t.co/IYVcF73stb

Transformative investment of $4M from FedDev for the Centre for Collaborative Chemistry at McMaster University. The C3 will be an anchor tenant for @MacGlobalNexus and other research hubs @McMasterU and @BBS_McMasterU for made-in-Canada drug products.

We’re pleased to support @McMasterU’s new Centre for Collaborative Chemistry (C3) with a $4M investment! C3 will fast-track the development and commercialization of life-changing medications—improving the lives of Canadians, creating jobs, and growing our life-sciences sector.

A great day to welcome @FilomenaTassi to campus to announce $4M via @FedDevOntario for our Centre for Collaborative Chemistry (C3). Thank you! McMaster is better positioned than ever to help get new therapies to market. https://t.co/QNLKfu9uyj

The Government of Canada announced today a $4M investment in Global Nexus, which will be leveraged for bold new drug discovery and development initiatives at McMaster. https://t.co/rAcROOFicc

We are so grateful for the support from McMaster HealthLabs. This funding will enable critical translation activities that will bring health discoveries closer to the patients who need them. #NationalPhilanthropyDay https://t.co/DqRizhnJqM

Global Nexus and @McMasterIIDR director @Millerlab_atMac moderated the biomanufacturing panel at the @NGBIdeas summit today. The panel featured a quartet of top life sciences experts from across Canada. #NGBiSummit

From transmission to symptoms, what to know about avian flu after B.C. case. Matthew Miller (@Millerlab_atMac), director @McMasterIIDR & @MacGlobalNexus, spoke with @CdnPressNews about the symptoms of H5N1 and how it differs from seasonal flu. https://t.co/tAlDd1gRzp

Meet Dr. Matthew Miller, Executive Director at @McMasterU ’s Global Nexus & @McMasterIIDR , focused on pandemic prevention and groundbreaking vaccines. He will be moderating the Biomanufacturing panel at #NGBi2024 on November 12th at the Hamilton Convention Center. Head to

Meet Matthew Miller, Director of the IIDR and @MacGlobalNexus. He's working on pandemic prevention measures, like vaccines and therapeutics, that provide protection against large viral families. Today, @Millerlab_atMac will be inducted into the @src_rsc's College of New Scholars!

A @McMasterU-affiliated biotech is expanding to @MIP_Hamilton, where it will intensify its drug discovery efforts with new assets, talent, and tech. 👇 https://t.co/dfYSBXzAOu

.@MacGlobalNexus researchers collaborate to shorten the long & winding road to drug discovery. Jakob Magolan & Sheila Singh (@sheilasinghlab) on their unique approach to developing a new anti-cancer medicine. 👇 @BBS_McMasterU @McMasterSurgery @CDCR_Mac https://t.co/s6ekAGBJHQ

Efficiently moving new drugs from academic labs to the patients who need them is mission-critical at Global Nexus. Here, researchers Jakob Magolan and Sheila Singh discuss how they're working together to bring important new cancer drugs to market. https://t.co/RFxrNfgQfD

Matthew Miller (@Millerlab_atMac), director @McMasterIIDR and @MacGlobalNexus, spoke with @OttawaCitizen about COVID-19 and the general need for mucosal vaccines—next-generation vaccines that are needle-free and can be sprayed or inhaled. https://t.co/qW84QFNP0P

Jakob Magolan, part of our executive team, is collaborating with neurobiologists on a new therapeutic approach to preventing cancer from spreading to the brain. https://t.co/MGQ8oIcRqb

HERC is perfectly aligned with our mission to drive impact through collaboration between academia, government, industry, and public health. As co-lead of a federally-funded pandemic preparedness hub (CP2H), we look forward to supporting ISED's growing life sciences strategy.

COVID-19 is surging again, driven by highly contagious Omicron sub-variants. @Millerlab_atMac tells @nationalpost that while the virus is evolving unpredictably, current vaccines still offer protection against severe infections, hospitalization, and death. https://t.co/SWd3skn5N5

It’s an incredible honour to have been elected to the Royal Society of Canada College of New Scholars! Humbling to join such accomplished colleagues from @McMasterU and across the country